![Fairooz Kabbinavar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fairooz Kabbinavar
Hoofd Techniek/Wetenschap/O&O bij CARDIFF ONCOLOGY, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Fairooz Kabbinavar
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARDIFF ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 31-01-2023 | - |
Loopbaan van Fairooz Kabbinavar
Eerdere bekende functies van Fairooz Kabbinavar
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2021 | 01-02-2023 |
University of California, Los Angeles | Corporate Officer/Principal | 01-07-1991 | 01-10-2016 |
FORTE BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 15-04-2019 | - |
Opleiding van Fairooz Kabbinavar
Nagpur University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
India | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Tocagen, Inc.
![]() Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Fairooz Kabbinavar
- Ervaring